FullSizeRender.jpeg

Alyssa Weddle

Having sickle cell disease used to mean Alyssa Weddle missed out on normal teenage things — going out with friends, school work, extracurricular activities. Now, after gene editing therapy, it’s been more than two years since the 16-year-old has been hospitalized for pain caused by sickle cell disease.

Weddle took part in a clinical trial for CRISPR-Cas9 gene editing therapy at TriStar Centennial beginning in 2021.

Frangoul.jpg

Haydar Frangoul

Recommended for you